Literature DB >> 6713338

Rebound of vasospastic angina after cessation of long-term treatment with nifedipine.

J Lette, R M Gagnon, J G Lemire, M Morissette.   

Abstract

The beneficial effect of calcium antagonists in the treatment of vasospastic angina is now well recognized. Although withdrawal symptoms have been reported following abrupt cessation of therapy with some cardiovascular drugs, there is no detailed report on similar complications of the cessation of therapy with calcium antagonists. In a 4-month period eight patients with well documented and well controlled vasospastic angina experienced a marked increase in the frequency and duration of anginal episodes at rest following the involuntary cessation of treatment with nifedipine, 10 to 20 mg four times a day. The increase began within 2 to 5 days after the cessation of treatment. Substitute therapy with isosorbide dinitrate, 30 mg, and verapamil, 80 to 120 mg, each four times a day, was effective in all cases. Although the mechanism responsible for this rebound phenomenon is not known, awareness of its existence is essential considering the widespread use of calcium antagonists.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713338      PMCID: PMC1876004     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  20 in total

Review 1.  Coronary-artery spasm.

Authors:  L D Hillis; E Braunwald
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

2.  Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management.

Authors:  L Hansson; S N Hunyor; S Julius; S W Hoobler
Journal:  Am Heart J       Date:  1973-05       Impact factor: 4.749

3.  Angina pectoris at rest with preservation of exercise capacity: Prinzmetal's variant angina.

Authors:  R N MacAlpin; A A Kattus; A B Alvaro
Journal:  Circulation       Date:  1973-05       Impact factor: 29.690

4.  Variant angina pectoris.

Authors:  R B Whiting; M D Klein; J Vander Veer; B Lown
Journal:  N Engl J Med       Date:  1970-03-26       Impact factor: 91.245

5.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

6.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients.

Authors:  A Maseri; S Severi; M D Nes; A L'Abbate; S Chierchia; M Marzilli; A M Ballestra; O Parodi; A Biagini; A Distante
Journal:  Am J Cardiol       Date:  1978-12       Impact factor: 2.778

7.  Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure.

Authors:  R L Lange; M S Reid; D D Tresch; M H Keelan; V M Bernhard; G Coolidge
Journal:  Circulation       Date:  1972-10       Impact factor: 29.690

8.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

9.  Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema.

Authors:  A Polese; C Fiorentini; M T Olivari; M D Guazzi
Journal:  Am J Med       Date:  1979-05       Impact factor: 4.965

10.  Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina.

Authors:  A Maseri; A L'Abbate; G Baroldi; S Chierchia; M Marzilli; A M Ballestra; S Severi; O Parodi; A Biagini; A Distante; A Pesola
Journal:  N Engl J Med       Date:  1978-12-07       Impact factor: 91.245

View more
  10 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Worsening of coronary spasm during the perioperative period: A case report.

Authors:  Hiroki Teragawa; Kenji Nishioka; Yuichi Fujii; Naomi Idei; Takaki Hata; Shuji Kurushima; Tomoki Shokawa; Yasuki Kihara
Journal:  World J Cardiol       Date:  2014-07-26

Review 3.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

Review 4.  Clinical roles of calcium channel blockers in ischemic heart diseases.

Authors:  Daisuke Sueta; Noriaki Tabata; Seiji Hokimoto
Journal:  Hypertens Res       Date:  2017-01-26       Impact factor: 3.872

5.  Prevention of vasospastic angina with nicardipine.

Authors:  C J Pepine; J S Gelman
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Evaluation of the antianginal effect of nifedipine: influence of formulation dependent pharmacokinetics.

Authors:  B W Karlson; H Emanuelsson; J Herlitz; J E Nilsson; G Olsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 7.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

8.  Clinical Outcomes of Vasospastic Angina Patients Presenting With Acute Coronary Syndrome.

Authors:  Sung Woo Cho; Taek Kyu Park; Hye Bin Gwag; A Young Lim; Min Seok Oh; Da Hyon Lee; Choong Sil Seong; Jeong Hoon Yang; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Sang Hoon Lee; Hyeon-Cheol Gwon; Seung-Hyuk Choi
Journal:  J Am Heart Assoc       Date:  2016-11-16       Impact factor: 5.501

Review 9.  Coronary artery spasm: Current knowledge and residual uncertainties.

Authors:  Massimo Slavich; Riyaz Suleman Patel
Journal:  Int J Cardiol Heart Vasc       Date:  2016-01-23

10.  Incidence and factors associated with mortality in 2,476 patients with variant angina in Korea.

Authors:  Hack-Lyoung Kim; Jayeun Kim; Hyun Joo Kim; Woo-Hyun Lim; Jin Yong Lee
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.